End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- KRW | -.--% | -.--% | -.--% |
2020 | Kosun Bio Co., Ltd. cancelled the transaction announced on September 2, 2019 | CI |
2020 | Kosun Bio Co., Ltd. cancelled the transaction announced on December 27, 2019 | CI |
Sales 2018 | 9.54B 7.02M 586M | Sales 2019 | 2.7B 1.98M 165M | Capitalization | 33.83B 24.9M 2.08B |
---|---|---|---|---|---|
Net income 2018 | -59.61B -43.87M -3.66B | Net income 2019 | -50.11B -36.88M -3.08B | EV / Sales 2018 | 7.52 x |
Net Debt 2018 | 1.53B 1.13M 93.83M | Net Debt 2019 | 5.66B 4.17M 348M | EV / Sales 2019 | 14.7 x |
P/E ratio 2018 |
-1.18
x | P/E ratio 2019 |
-0.67
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 74.3% |
Managers | Title | Age | Since |
---|---|---|---|
Kyu-Man Cho
CEO | Chief Executive Officer | 51 | 07/19/07 |
Jae-Cheol Ryu
AUD | Comptroller/Controller/Auditor | 56 | 07/19/07 |
Jong-Chul Lee
PRN | Corporate Officer/Principal | 59 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yeong-Chan Kim
BRD | Director/Board Member | 69 | 07/19/07 |
Jong-Chul Lee
PRN | Corporate Officer/Principal | 59 | - |
Kyu-Man Cho
CEO | Chief Executive Officer | 51 | 07/19/07 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 485K | |
+16.75% | 8.4B | |
+3.59% | 7.49B | |
+12.04% | 6.63B | |
-5.81% | 3.77B | |
-5.81% | 3.68B | |
+0.98% | 1.4B | |
+19.97% | 999M | |
-34.08% | 972M | |
-16.53% | 858M |
- Stock Market
- Equities
- A204990 Stock